Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2020-08-28 Interim / Quarterly Rep…
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Orphazyme announces Interim Report First Half 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report First Half 2020' and contains comprehensive financial statements, including a 'Condensed Consolidated Key Figures' table, profit or loss statements, balance sheets, and cash flow statements for the period ending June 30, 2020. It also includes management commentary on business performance, pipeline highlights, and outlook. This fits the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-28 English
Report Publication Announcement 2020
Report Publication Announcement Classification · 95% confidence The document is an announcement from Orphazyme regarding the release of their 'Interim Report First Half 2020'. While it contains summary financial highlights, it explicitly functions as a press release/announcement that provides a link to the actual report as an attachment ('Attachment: 45-2020 Orphazyme announces Interim Report First Half 2020'). Per the 'Menu vs Meal' rule, this is a report publication announcement rather than the full interim report itself. H1 2020
2020-08-28 English
Capital increase of 31,250 shares in Orphazyme A/S as a result of vesting and exercise of Matching Shares
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement regarding a capital increase resulting from the exercise of matching shares. It details the issuance of 31,250 new shares and the subsequent update to the total share capital and voting rights. This falls directly under the category of share issuance and capital changes.
2020-07-31 English
Capital increase of 31,250 shares in Orphazyme A/S as a result of vesting and exercise of Matching Shares
Share Issue/Capital Change Classification · 100% confidence The document is a company announcement regarding a capital increase of 31,250 shares due to the vesting and exercise of Matching Shares. It details the change in total nominal share capital and voting rights. This falls under the category of share issues or capital changes, which is explicitly defined as 'SHA'.
2020-07-31 English
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by persons discharging managerial responsibilities (PDMRs), specifically the CFO, CMO, and CSO of Orphazyme A/S. It explicitly cites the Market Abuse Regulation (MAR) article 19, which governs insider dealing and director transactions. This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2020-07-29 English
Director's Dealing 2020
Director's Dealing Classification · 99% confidence The document is titled "Reporting of transactions in Orphazyme's shares made by persons discharging managerial responsibilities" and explicitly states it is a notification pursuant to the Market Abuse Regulation article 19. It details share purchases made by the CFO, CMO, and CSO. This content directly corresponds to the definition of reporting personal share transactions by company directors and executives, which maps to the 'Director's Dealing' filing type.
2020-07-29 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.